GLOBAL MARKETS LIVE: Berkshire Hathaway, Johnson & Johnson, AstraZeneca…
|03/01/2021 | 10:20am|
AstraZeneca sold its entire stake in Moderna, Berkshire Hathaway topped expectations, Robinhood plans to file for IPO, and McDonald is about to sell some of its assets.
Berkshire Hathaway's Q4 results exceeded expectations.
Logitech raised its 2020/2021 objectives, an exceptional year, and communicated its expectations for the next and medium term.
Johnson & Johnson's single-dose vaccine validated by the U.S. FDA.
SoftBank seals an agreement with WeWork.
Deutsche Bank is again involved in an obscure case, this time involving foreign exchange derivatives in Spain.
Starwood raises its offer on CA Immobilien to EUR 36.
Aviva aims for carbon neutrality by 2040.
AstraZeneca sold its entire 7.7% stake in Moderna in fiscal year 2020. According to The Times, the sale brought more than one billion dollars to AstraZeneca.
Ferrari will propose a dividend of 0.867 EUR.
In Mongolia, Rio Tinto and the authorities agree to review the terms of a giant $7 billion mining project.
McDonald's plans to sell part of Dynamic Yield, according to the Wall Street Journal.
Takeda will divest four diabetes products in Japan to Teijin Pharma Limited.
Idorsia is filing for approval in Japan for clazosentan.
Santhera announces positive results with Ionodelestat in cystic fibrosis.
Julius Bär launches a new share buyback program.
According to Bloomberg, Robinhood plans to file for IPO in March.